Bleximo is a Superconducting Qubits company founded in 2017 and based in Berkeley, United States. It has raised $1.5M in total funding, most recently a Seed in 2018.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Sep 25, 2018 | Seed | $1.5M | — | Eniac Ventures |
No articles ingested yet for Bleximo. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.
Application-specific superconducting quantum processor co-designed with algorithms for quantum chemistry simulation. Optimized for molecular energy calculations relevant to pharmaceutical drug discovery and materials science rather than general-purpose gate-model computing. Each qASIC is tailored to a specific problem class, allowing higher performance on targeted workloads compared to programmable universal quantum computers. Targets near-term advantage in simulation tasks intractable for classical hardware.
In-house cryogenic test platform enabling rapid characterization and optimization of superconducting quantum chips. Supports the iterative co-design process that Bleximo uses to tune hardware alongside quantum chemistry algorithms. Accompanied by Quantum Chip Optimization (QCO) software for automated layout generation and performance prediction of superconducting circuits before fabrication.